Dividend Edwards Lifesciences Corporation
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.66 USD | -0.92% |
|
-0.82% | -1.87% |
| 01-22 | Leerink Partners Adjusts Edwards Lifesciences Price Target to $88 From $87, Maintains Market Perform Rating | MT |
| 01-22 | Venus Medtech Clarifies U.S. Patent Lawsuit Involving Subsidiary | MT |
EPS & Dividend: Edwards Lifesciences Corporation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.3 | 2.38 | 2.44 | 2.3 | 6.97 | 2.268 | 2.744 | 3.041 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 91.23 | 129.55 | 74.61 | 76.25 | 74.03 | 83.66 | 83.66 | 83.66 |
| Nbr of stocks (in thousands) | 623,248 | 624,334 | 618,260 | 606,500 | 589,800 | 580,300 | 580,300 | - |
| Announcement Date | 27/1/21 | 26/1/22 | 31/1/23 | 6/2/24 | 11/2/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Edwards Lifesciences Corporation
More events
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | 36.89x | 4.54x | 7.47x | |
| 0.26% | 0.27% | 35.09x | 4.51x | 5.95x | |
| -.--% | -.--% | 70.13x | 9.82x | 18.15x | |
| 0.53% | 0.58% | 45.08x | 3.26x | 7.32x | |
| -.--% | -.--% | 45.38x | 5.56x | 7.27x | |
| 2.41% | 2.74% | 20.89x | 2.52x | 2.45x | |
| 0.76% | 0.8% | 25.32x | 4.89x | 5.33x | |
| 0.17% | 0.2% | 17.4x | 3.45x | 2.02x | |
| 0.96% | 1.07% | 24.03x | 5.4x | 6.35x | |
| 2.68% | 3.06% | 24.67x | 6.04x | 6.33x | |
| Average | 0.78% | 0.87% | 34.49x | 5.00x | 6.86x | |
| Weighted average by Cap. | 0.46% | 0.51% | 42.35x | 5.40x | 8.42x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition